To assess the relationship between second and third trimester glycemic control and adverse outcomes in pregnant women with type 1 diabetes, as uncertainty exists about optimum glycemic targets. RESEARCH DESIGN AND METHODS Pregnancy outcomes were assessed prospectively in 725 women with type 1 di-abetes from theDiabetes and Pre-eclampsia Intervention Trial. HbA1c (A1C) values at 26 and 34weeks ’ gestationwere categorized into five groups, the lowest, <6.0% (42 mmol/mol), being the reference. Average pre- and postprandial results from an eight-point capillary glucose profile the previous day were categorized into five groups, the lowest (preprandial <5.0 mmol/L and postprandial <6.0 mmol/L) being the reference. RESULTS An A1C of 6.0–...
Background: Pregestational diabetes mellitus (PGDM) confers an increased risk of adverse maternal an...
Background and Objective. Diabetes mellitus is a metabolic disorder characterized by the presence of...
The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to capillary glucose mo...
To assess the relationship between second and third trimester glycemic control and adverse outcomes ...
OBJECTIVE: The optimal method of monitoring glycemia in pregnant women with type 1 diabetes remains ...
OBJECTIVE: The optimal method of monitoring glycemia in pregnant women with type 1 diabetes remains ...
AbstractAimWe wanted to investigate third-trimester HbA1c as a predictor of diabetes after gestation...
The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to capillary glucose mo...
OBJECTIVE—To assess the relationship between glycemic control, pre-eclampsia, and ges-tational hyper...
Background The optimal glycaemic control target in pregnant women with pre-existing diabetes is uncl...
Aim We wanted to investigate third-trimester HbA1c as a predictor of diabetes after gestational diab...
Aim: to compare pregnancy outcomes in type 1 diabetic pregnancies with the general population and th...
OBJECTIVEdPregnancy in type 1 diabetes requires excellent glycemic control. Most preg-nant type 1 di...
INTRODUCTION Our aim was to investigate the prognostic value of first-trimester glycosylated hemo...
Context: Diabetes in pregnancy (DIP) is either pregestational or gestational. Aims: To determine th...
Background: Pregestational diabetes mellitus (PGDM) confers an increased risk of adverse maternal an...
Background and Objective. Diabetes mellitus is a metabolic disorder characterized by the presence of...
The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to capillary glucose mo...
To assess the relationship between second and third trimester glycemic control and adverse outcomes ...
OBJECTIVE: The optimal method of monitoring glycemia in pregnant women with type 1 diabetes remains ...
OBJECTIVE: The optimal method of monitoring glycemia in pregnant women with type 1 diabetes remains ...
AbstractAimWe wanted to investigate third-trimester HbA1c as a predictor of diabetes after gestation...
The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to capillary glucose mo...
OBJECTIVE—To assess the relationship between glycemic control, pre-eclampsia, and ges-tational hyper...
Background The optimal glycaemic control target in pregnant women with pre-existing diabetes is uncl...
Aim We wanted to investigate third-trimester HbA1c as a predictor of diabetes after gestational diab...
Aim: to compare pregnancy outcomes in type 1 diabetic pregnancies with the general population and th...
OBJECTIVEdPregnancy in type 1 diabetes requires excellent glycemic control. Most preg-nant type 1 di...
INTRODUCTION Our aim was to investigate the prognostic value of first-trimester glycosylated hemo...
Context: Diabetes in pregnancy (DIP) is either pregestational or gestational. Aims: To determine th...
Background: Pregestational diabetes mellitus (PGDM) confers an increased risk of adverse maternal an...
Background and Objective. Diabetes mellitus is a metabolic disorder characterized by the presence of...
The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to capillary glucose mo...